Additional infusions of mesenchymal stem cells improve response rate in multidrug-resistant GvHD patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
http://www.nature.com/articles/bmt20171.pdf
Reference13 articles.
1. Ferrara JL, Levine JE, Reddy P, Holler E . Graft-versus-host disease. Lancet 2009; 373: 1550–1561.
2. Bacigalupo A . Management of acute graft-versus-host disease. Br J Haematol 2007; 137: 87–98.
3. Kebriaei P, Isola L, Bahceci E, Holland K, Rowley S, McGuirk J et al. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant 2009; 15: 804–811.
4. Figueroa FE, Carrión F, Villanueva S, Khoury M . Mesenchymal stem cell treatment for autoimmune diseases: a critical review. Biol Res 45: 269–277.
5. Voswinkel J, Francois S, Gorin NC, Chapel A . Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut graft versus host disease by mesenchymal stromal cells. Immunol Res 2013; 56: 241–248.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease;World Journal of Stem Cells;2023-04-26
2. Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation;Annals of Hematology;2023-04-17
3. The efficiency of human umbilical cord mesenchymal stem cells as a salvage treatment for steroid-refractory acute graft-versus-host disease;Clinical and Experimental Medicine;2023-01-04
4. Mesenchymal stroma/stem cells: Haematologists’ friend or foe?;British Journal of Haematology;2022-06-06
5. Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation;THER ADV HEMATOL;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3